Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
Date:8/11/2008

XI'AN, China, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it has signed a major supply agreement with DNP International Co., Inc. of Santa Fe Springs, CA.

Under the terms of the agreement Huifeng is to deliver 62 metric tons of Glucuronolactone, a naturally occurring chemical compound which has become a popular additive to energy drinks, over the next six months to DNP. The total dollar amount of the contract is in excess of USD $1.1 Million.

Huifeng anticipates signing additional bi-annual contracts with DNP upon successful completion of the first agreement.

''Our agreement with DNP further demonstrates the increasing international acceptance of Huifeng products. With quality and consistency as our hallmarks, we are now becoming recognized by major US corporations for the quality and consistency of the products we develop and manufacture,'' stated company CEO Jing'An Wang. ''We are pleased to be making further inroads into the US market and hope to sign similar supply agreements with DNP and other US entities in the near future.''

About Glucuronolactone

Glucuronolactone is a naturally occurring chemical compound produced by the metabolism of glucose in the human liver. It is an important structural component of nearly all connective tissues. The most common usage for Glucuronolactone is in many energy drinks. Because most of these drinks also contain caffeine, Glucuronolactone is included because it is purported to fight fatigue and provide a sense of well-being. According to "The Merck Index" (14th edition) it is also used as detoxicant. (From Wikipedia)

About DNP International

DNP International imports and distributes raw material ingredients to manufacturers in the nutritional supplements, food, beverage, feed, cosmetics and pharmaceutical industries. Founded in 1994, DNP is one of the largest suppliers of raw materials in the United States and sources over 2,500 different ingredients. http://www.dnpint.com/

About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/

For more information, please contact:

Dan Carlson,

Primary Capital LLC

Email: DCarlson@PrimaryLLC.com

Kelly Black, CEO

Premier Media Services, Inc.

Tel: +1-480-649-8224


'/>"/>
SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
2. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status
3. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
4. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
5. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
6. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
7. Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
8. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
9. Sentry Enhances Offerings with Temperature-Controlled Custom Bio-Pharmaceutical Finishing Services
10. Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
11. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... and WASHINGTON , March 28, ... provider, GENEWIZ, will launch single-cell sequencing during the American Association ... E. Washington Convention Center in Washington, D.C. ... to perform differential gene expression of thousands of cells ... Experts on-hand at AACR ...
(Date:3/28/2017)... March 28, 2017 Dr. Chris ... sciences corporation Anpac Bio-Medical Science Company , ... international record, processing and reporting over 40,000 cases ... Analysis" (CDA) liquid biopsy tests. ... Laureate Summit publications, Anpac Bio,s CDA medical devices ...
(Date:3/28/2017)... March 28, 2017 Focus ... unpredictable sector due to the scientifically intensive operations ... medical, agricultural, environmental, and industrial. In today,s pre-market research, ... Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: OVAS), ... Inc. (NASDAQ: OCUL ). Learn more ...
(Date:3/28/2017)... ... March 28, 2017 , ... Executive ... Officer with Avomeen Analytical Services. Harvill is a distinguished life sciences expert with ... Avomeen is a leader in a wide range of services related to laboratory ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
Breaking Biology News(10 mins):